Coleen M. Clineschmidt

1.0k total citations
9 papers, 685 citations indexed

About

Coleen M. Clineschmidt is a scholar working on Ophthalmology, Infectious Diseases and Small Animals. According to data from OpenAlex, Coleen M. Clineschmidt has authored 9 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Ophthalmology, 3 papers in Infectious Diseases and 2 papers in Small Animals. Recurrent topics in Coleen M. Clineschmidt's work include Glaucoma and retinal disorders (4 papers), Parasitic Diseases Research and Treatment (2 papers) and Drug-Induced Ocular Toxicity (2 papers). Coleen M. Clineschmidt is often cited by papers focused on Glaucoma and retinal disorders (4 papers), Parasitic Diseases Research and Treatment (2 papers) and Drug-Induced Ocular Toxicity (2 papers). Coleen M. Clineschmidt collaborates with scholars based in United States, France and Switzerland. Coleen M. Clineschmidt's co-authors include Robert Tipping, Christine Furtek, Cong Chen, Cynthia Guzzo, Kenneth C. Lasseter, Arturo G. Porras, David Sciberras, Ingrid Adamsons, Ellen Snyder and John Y‐K. Hsieh and has published in prestigious journals such as Ophthalmology, The Journal of Pediatrics and Clinical Pharmacology & Therapeutics.

In The Last Decade

Coleen M. Clineschmidt

9 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Coleen M. Clineschmidt United States 8 363 214 165 164 119 9 685
Ashley M Croft United Kingdom 12 82 0.2× 81 0.4× 33 0.2× 210 1.3× 20 0.2× 29 553
José A. Hidalgo United States 16 291 0.8× 30 0.1× 26 0.2× 26 0.2× 13 0.1× 46 882
Thamrong Chirachariyavej Thailand 11 100 0.3× 32 0.1× 7 0.0× 127 0.8× 17 0.1× 20 377
Jane Lafferty United Kingdom 10 204 0.6× 590 2.8× 7 0.0× 49 0.3× 28 0.2× 12 1.4k
Vanessa R Anderson United States 12 90 0.2× 69 0.3× 15 0.1× 23 0.1× 17 0.1× 17 530
Take Naseri United States 15 150 0.4× 61 0.3× 10 0.1× 276 1.7× 3 0.0× 73 746
A. B. G. Laing Gambia 16 269 0.7× 66 0.3× 5 0.0× 238 1.5× 13 0.1× 45 650
Dorothy Bonn 12 82 0.2× 10 0.0× 13 0.1× 90 0.5× 15 0.1× 136 592
P Gaxotte France 13 474 1.3× 327 1.5× 5 0.0× 105 0.6× 107 0.9× 34 704
Jeffrey D. Whitman United States 13 253 0.7× 80 0.4× 3 0.0× 277 1.7× 15 0.1× 28 862

Countries citing papers authored by Coleen M. Clineschmidt

Since Specialization
Citations

This map shows the geographic impact of Coleen M. Clineschmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Coleen M. Clineschmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Coleen M. Clineschmidt more than expected).

Fields of papers citing papers by Coleen M. Clineschmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Coleen M. Clineschmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Coleen M. Clineschmidt. The network helps show where Coleen M. Clineschmidt may publish in the future.

Co-authorship network of co-authors of Coleen M. Clineschmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Coleen M. Clineschmidt. A scholar is included among the top collaborators of Coleen M. Clineschmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Coleen M. Clineschmidt. Coleen M. Clineschmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Guzzo, Cynthia, Christine Furtek, Arturo G. Porras, et al.. (2002). Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects. The Journal of Clinical Pharmacology. 42(10). 1122–1133. 215 indexed citations
2.
Guzzo, Cynthia, Christine Furtek, Arturo G. Porras, et al.. (2002). Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects. The Journal of Clinical Pharmacology. 42(10). 1122–1133. 249 indexed citations
3.
Meinking, Terri L., Coleen M. Clineschmidt, Cong Chen, et al.. (2002). An observer-blinded study of 1% permethrin creme rinse with and without adjunctive combing in patients with head lice. The Journal of Pediatrics. 141(5). 665–670. 41 indexed citations
4.
Adamsons, Ingrid, Coleen M. Clineschmidt, Adam B. Polis, et al.. (1998). The Efficacy and Safety of Dorzolamide as Adjunctive Therapy to Timolol Maleate Gellan Solution in Patients with Elevated Intraocular Pressure. Journal of Glaucoma. 7(4). 247???260–247???260. 19 indexed citations
6.
Gunning, Frans P., A Béchetoille, Erik A. Lippa, et al.. (1992). Sezolamide: Additivity to timolol twice daily. Eye. 6(5). 525–529. 4 indexed citations
7.
Vogel, Roger, et al.. (1992). Effect of Timolol versus Pilocarpine on Visual Field Progression in Patients with Primary Open-angle Glaucoma. Ophthalmology. 99(10). 1505–1511. 17 indexed citations
8.
Buclin, Thierry, Jérôme Biollaz, Erik A. Lippa, et al.. (1991). Absence of metabolic effects of the topical carbonic anhydrase inhibitors MK-927 and sezolamide during two-week ocular administration to normal subjects. Clinical Pharmacology & Therapeutics. 49(6). 665–673. 11 indexed citations
9.
Vogel, Roger, et al.. (1990). The Effect of Timolol, Betaxolol, and Placebo on Corneal Sensitivity in Healthy Volunteers. Journal of Ocular Pharmacology and Therapeutics. 6(2). 85–90. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026